Global Antimicrobial Susceptibility Testing Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Access Full Report: https://databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market/
The global antimicrobial susceptibility testing market highly concentrated to a few big players and rest to local players who cater to domestic markets only. bioMérieux SA dominated the antimicrobial susceptibility testing market accounting for a highest market share in 2017, followed by Thermo Fisher Scientific, BD, Bio-Rad Laboratories among others.
Founded in 1963 and headquartered in Marcy l’Etoile, France. bioMérieux SA. provides the in vitro diagnostic solutions for private and hospital laboratories, mainly for the diagnosis of infectious diseases. The company operates in industrial application, molecular biology, immunoassays, microbiology, other lines business segments
The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe. The subsidiary of bioMérieux SA. are bioMérieux Kenya Limited ( kenya), bioMérieux SRB ( Serbia), BioFire Diagnostics, LLC (U.S), Biomérieux Brasil S.A. (Brazil) , NORVEGE (Oslo) and among others.
Thermo Fisher Scientific Inc.:
Founded in 1956 and headquartered in Massachusetts, U.S. Thermo Fisher Scientific Inc. provides the accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. The company operates in analytical instruments, life sciences solutions, specialty diagnostics, laboratory products & services other lines business segments.
The company’s regional locations are Asia Pacific, Europe, North America and rest of the world. The subsidiary of Thermo Fisher Scientific Inc are Dionex (california), Patheon N.V. (Netherlands), Fisher Scientific Co LLC (U.S), FEI Company (U.S), Affymetrix (U.S), Nalge Nunc International (U.S). and among others.
Founded in 1897 and headquartered in New Jersey, U.S. The company engaged with the development, manufacture of medical devices, laboratory equipments, diagnostic healthcare for pharmaceutical company, clinical laboratories and others. The company operates in BD medical, BD life sciences business segments.
The company’s regional locations are United States, Europe , Greater Asia and others. The subsidiary of BD are Discovery Labware Inc.(U.S.), Nippon Becton Dickinson Co. Ltd. (Japan), Stanford University (U.S.), Cellular Research, Inc. (California), Becton Dickinson Canada Inc (Canada), , PreAnalytiX GmbH (Switzerland) and others.
Global Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2027
North America Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2027
Europe Antimicrobial Susceptibility Testing Market– Industry Trends and Forecast to 2025
Asia-Pacific Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2027
Middle East and Africa Antimicrobial Susceptibility Testing Market – Industry Trends and Forecast to 2027